Tang, Yong, and Yibin Kang. (2022) 2022. “Microbial Metabolite As Icebreaker for Immunotherapy”. Cell Metab 34 (4): 506-7. doi:10.1016/j.cmet.2022.03.003.

Meng, Jingjing, Yi-Zhou Jiang, Shen Zhao, Yuwei Tao, Tengjiang Zhang, Xuxiang Wang, Yuan Zhang, et al. (2022) 2022. “Tumor-Derived Jagged1 Promotes Cancer Progression through Immune Evasion”. Cell Rep 38 (10): 110492. doi:10.1016/j.celrep.2022.110492.

Shen, Minhong, Yong Wei, Hahn Kim, Liling Wan, Yi-Zhou Jiang, Xiang Hang, Michael Raba, et al. (2022) 2022. “Small-Molecule Inhibitors That Disrupt the MTDH-SND1 Complex Suppress Breast Cancer Progression and Metastasis”. Nat Cancer 3 (1): 43-59. doi:10.1038/s43018-021-00279-5.

Pérez-Núñez, Iván, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández-Prat, et al. (2022) 2022. “LCOR Mediates Interferon-Independent Tumor Immunogenicity and Responsiveness to Immune-Checkpoint Blockade in Triple-Negative Breast Cancer”. Nat Cancer 3 (3): 355-70. doi:10.1038/s43018-022-00339-4.

Ghergurovich, Jonathan, Mark Esposito, Zihong Chen, Joshua Wang, Vrushank Bhatt, Taijin Lan, Eileen White, Yibin Kang, Jessie Yanxiang Guo, and Joshua Rabinowitz. (2020) 2020. “Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis”. Cancer Res 80 (18): 3820-29. doi:10.1158/0008-5472.CAN-19-2486.

Goode, Gennifer, Billy Ballard, Charles Manning, Michael Freeman, Yibin Kang, and Sakina Eltom. (2013) 2013. “Knockdown of Aberrantly Upregulated Aryl Hydrocarbon Receptor Reduces Tumor Growth and Metastasis of MDA-MB-231 Human Breast Cancer Cell Line.”. Int J Cancer 133 (12): 2769-80. doi:10.1002/ijc.28297.

Cicchini, Michelle, Rumela Chakrabarti, Sameera Kongara, Sandy Price, Ritu Nahar, Fred Lozy, Hua Zhong, Alexei Vazquez, Yibin Kang, and Vassiliki Karantza. 2014. “Autophagy Regulator BECN1 Suppresses Mammary Tumorigenesis Driven by WNT1 Activation and Following Parity.”. Autophagy 10 (11): 2036-52. doi:10.4161/auto.34398.